CYTEIR THERAPEUTICS, INC. LEDGEMONT RESEARCH CENTER LEXINGTON, MALease Agreement • March 26th, 2021 • Cyteir Therapeutics, Inc. • Pharmaceutical preparations
CYTEIR THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT FEBRUARY 5, 2021Investors’ Rights Agreement • March 26th, 2021 • Cyteir Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Second Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of February 5, 2021, by and among Cyteir Therapeutics, Inc., a Delaware corporation (the “Company”) and each of the individuals and entities listed on Schedule A (together with any subsequent investors, or transferees, who become parties hereto pursuant to Subsection 6.9 below, the “Investors”).
FIRST AMENDMENT TO LEASELease • March 26th, 2021 • Cyteir Therapeutics, Inc. • Pharmaceutical preparations
This First Amendment to Lease (“First Amendment”) is executed as of the 15th day of October, 2019, by and between 128 Spring Street Lexington, LLC, as landlord (“Landlord”) and Cyteir Therapeutics, Inc., as tenant (“Tenant”).
